Closure of Trading Window for the Quarter Ending 30th September 2026

AHCL/SE/30/2026-27 September 25, 2026 The National Stock Exchange of India BSE Limited Limited Department of Corporate Services “Exchange Plaza”, C-1, Block G 1st Floor, Bandra-Kurla Complex, Bandra (E) P.J. Towers, Dalal Street, Mumbai 400 051 Mumbai 400 001 ISIN: INE098F01031 Symbol: AMRUTANJAN Scrip Code: 590006 Dear Sir/ Madam, Sub: Intimation of closure of Trading Window Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, and the Company’s Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Designated Persons from October 1, 2026 till the conclusion of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending September 30, 2026. The Designated Persons have been requested not to enter into any transaction involving the securities of the Company during aforesaid period of closure of Trading Window. Request you to take the above on record. For Amrutanjan Health Care Limited Gagan Preet Singh General Manager - Legal Company Secretary & Compliance Officer Amrutanjan Health Care Limited I 03, (Old No. 42-45), Luz Church Road, E-mail : customercare@amrutanjan.com Mylapore, Chennai - 600 004 WebSite : www. amrutanjan.com Tamil Nadu, India. Toll Free No.: I • 800 - 425 - 4545 Tel :+91-44 - 2499 4465 CIN - L24231TN1936PLC000017 +91-44 • 2466 9000 Fax :+91-44 - 2499 4585